Description
BLOOD
First action · last action
2024-10-01 · 2026-07-01
Transactions
2
First transaction's obligation
$375,761
Base + all options value (sum of deltas)
$162,074
Extent competed
NOT AVAILABLE FOR COMPETITION
Other than full & open authority
AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I))
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24924D0098
NAICS
325414 · BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-10-01+$375,761= $375,761
- Mod P000012026-07-01-$213,687= $162,074
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-10-01 | +$375,761 | $375,761 | BLOOD |
| Mod P00001· FUNDING ONLY ACTION | 2026-07-01 | −$213,687 | $162,074 | BLOOD |
Related awards · 9
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PNAEF6YNHFY4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0127 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C25626N0209 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $71,646 | FY2026 |
| 36C25626N0210 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $239,128 | FY2026 |
| 36C24926N0133 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $390,791 | FY2026 |
| 36C25625N0105 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $144,871 | FY2025 |
| 36C25625N0078 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $6,152 | FY2025 |
Other recipients under 6506 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24926N0200 | BLOODSOLUTIONS MANAGERS, LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $594,875 | FY2026 |
| 36C24926A0003 | BLOODSOLUTIONS MANAGERS, LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $0 | FY2026 |
| 36C24925P0025 | BLOODSOLUTIONS MANAGERS, LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $399,994 | FY2025 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24925N0158_3600_36C24924D0098_3600 · retrieved 2026-09-26.